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ABSTRACT
The mini-review stemmed from a recent meeting on
national aging research strategies in China discusses
the components and challenges of aging research in
China. Highlighted are the major efforts of a number of
research teams, funding situations and outstanding ex-
amples of recent major research achievements. Finally,
authors discuss potential targets and strategies of aging
research in China.
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INTRODUCTION
According to China Aging Development Report (2013), the
severity of the aging population China faced is rarely seen
elsewhere in the world. By the end of 2012, China’s elderly
population (aged 60 and above) had totaled 194 million,
taking up 14.3% of total population; the elderly population
aged 65 and above had reached 123 million—constituting
one ﬁfth of the world’s elderly population. By 2030, China’s
elderly population is expected to reach 400 million, equiva-
lent to the total population of 15 EU countries. China is the
country with not only the world’s largest population, but also
a country holds the largest elderly population.
The increases in age-related diseases and the conse-
quent rise in health care costs caused by the decline in the
health status along with the aging of the population have
brought increasing pressure and burden to the society,
families and individuals (Christensen et al., 2009). Therefore,
issues such as the rapid increase in the elderly sub-health
status, and the prevention and treatment of the aging tis-
sues/organs as well as age-related diseases need to be
solved in our aging society. Cell senescence is thought to be
the main driving-force of the aging of tissues and organs.
The uneven aging of tissues and organs leads to a rapid
tissue/organ degeneration, hence resulting in age-related
diseases, such as brain degenerative disease, cardiovas-
cular disease, cancer, diabetes, reproductive dysfunction,
muscle atrophy, arthritis, and osteoporosis. The solution to
cell senescence including promoting stem cell research may
provide vital opportunities in tackling of the healthy aging
problem, and prevention and treatment of age-related
diseases.
Major breakthroughs have been made sometimes in
order to understand the mechanisms of how to improve the
health issues associated with the aging population. Such
challenges are not only faced by China and other developing
countries, but are also serious problems for many more
economically developed countries. In comparison to other
research ﬁelds, aging and anti-aging researches have en-
countered greater magnitudes of challenges, e.g. the inevi-
table, elusive, and asymptotic biological aging process, the
early failure of excessive pursuit of longevity, the deﬁciency
of public understanding in the urgency of aging research in
order to preventing aging related diseases. These im-
pediments have hindered aging research development and
consequently, led to a dramatic lag behind in preventing
aging-related sub-health state and aging-related diseases.
Therefore, it is a pressing and signiﬁcant scientiﬁc task to
conduct extensive and in-depth studies of the biological
process of aging and anti-aging processes in the human
body, tissues and organs, to unveil the damage and de-
generation caused by aging, as well as the right approaches
to enhance and promote anti-aging conditions and
mechanisms. Such endeavor will help realize the improve-
ment of the life quality and health of the elderly population,
the prevention and early treatment of aging-related diseases,
and the relief of the burden on individuals, families and the
society originated from the rising aging populations. Cur-
rently, clarifying the mechanisms underlying the occurrence
and development of aging, gathering anti-aging positive
energy to stimulate healthy aging, reducing and postponing
the occurrence of geriatric diseases, as well as optimizing
© The Author(s) 2015. This article is published with open access at Springerlink.com and journal.hep.com.cn










life quality and prolonging human lifespan are the popular
areas and important goals of the multi-disciplinary (including
medicine, life sciences, chemistry, and information sciences)
joint research.
FUNDING OF AGING RESEARCH
Research on aging and related diseases in China has re-
ceived signiﬁcant support from the National Natural Science
Foundation of China (NSFC), the Ministry of Science and
Technology of China (MOST), the National Health and
Family Planning Commission of China (NHFPC), and local
departments over the last decades. NSFC has supported
approximately 55 million of US dollars on aging research
over the past decade (Fig. 1). The supporting mechanisms
vary, including general program, key program, and interna-
tional joint-program, etc. In the NSFC-CIHR Health Re-
search Cooperation Program in 2009, an aging, geriatric
medicine and gerontology research scheme was established
separately for the research on body ﬂexibility and aging,
cognitive damage and aging. In 2013, the NHFPC and the
National Working Commission on Aging jointly issued the
China’s Elderly Health Guide aimed at promoting healthy
lifestyles, strengthening disease prevention, and improving
the life quality and health of the elderly ones. The severity
and fast development of population aging, the health care
and social insurance problems have become increasingly
prominent in China. It has been an important strategic de-
mand and developmental deployment during China’s 12th
and 13th Five-Year Plan period. To better promote the health
and sustainable development of aging research in China, the
Department of Health Sciences, Department of Life
Sciences and Policy Bureau of NSFC jointly held the 102th
Shuangqing Forum entitled “Key Scientiﬁc Issues of Aging
Translational Medical Research”, and nearly 50 experts and
scholars from more than 30 universities and research insti-
tutes at home and abroad attended the forum to discuss
national strategies in aging and related diseases. With the
aggravation of population aging and the government’s con-
stant seeking of the countermeasures, and for the needs of
the society, aging and anti-aging research have become an
elevating trend in the society, the academia, science, and
technology circle, as well as the service industries. A number
of aging-related research laboratories, centers, and research
institutions have been established in different cities, sharing
research tasks of universities, local governments and the
central government. Certain achievements have been made
in the aging and age-related disease research, and further
development and more breakthroughs on human anti-aging
research may be on the way.
AGING RESEARCH TEAMS IN CHINA
In recent years, China has made signiﬁcant progress in the
research of aging and anti-aging, and the underlying
mechanisms. A number of funding programs, such as
“Thousand Talents Program (Recruitment Program of Global
Experts)”, “National Science Fund for Distinguished Young
Scholars”, distinguished professors of “Changjiang Scholars
Program”, and “Hundred Talents Program of the Chinese
Academy of Sciences” have been in place to encourage
biomedical research including aging and anti-aging research.
A brief of made-in-China achievements and summaries in
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Figure 1. NSFC grant supports to aging research in China since 1986.
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Research in organismal, tissue-speciﬁc aging,
and related diseases
Various lines of research on telomeres in blood vessels, bone
marrows, adrenal glands, ovaries were previously reported
(Cao et al., 2002; Ju et al., 2007; Bayne et al., 2008; Yang et al.,
2009; Bayne et al., 2011). A sharp decline in estrogen levels is
associated with an increased impact of oxidative stress on cell
telomere length and decreased stem cell activity of follicular
granulosa cells during ovarian aging (Wang et al., 2012b; Zuo
et al., 2012). Midlife hepatic gene expressions correlated with
diet-induced lifespan under different dietary conditions in mice.
While increased mitochondrial gene expressions underpin
lifespanagainst aging-relatedchanges, decreasedperoxisomal
gene expressions extended the lifespan of Drosophila me-
lanogaster andCaenorhabditis elegans by decreasing peroxide
levels (Zhou et al., 2012). Mutations of nuclear lamina protein A
led to the dislocation of speciﬁc histone modiﬁcation enzyme
MOF and SUV39H1 in HGPS and Zmpste24 knockout mice,
resulting in epigenetic alterations, chromatin abnormalities and
ﬁnally impairedDNA repair (Liu et al., 2005; Liu et al., 2012a; Liu
et al., 2013). Recently, the mtDNA haplogroup F gene was
found to be associated with healthy longevity in female Chuang
population, that thealleleCETP405V is protective inAshkenazi
Jews but may be a risk allele against longevity in the Chinese
population, and that the gene interaction between CETP and
APOE polymorphisms confers higher risk of hypertriglyc-
eridemiaonChinesewomen (Fenget al., 2011;Sunet al., 2013;
Sun et al., 2014). In human centenarian samples, Foxo1a,
Foxo3a, and β-adrenergic receptor-2 were associated with
longevity via regulating vascular function, which may subject to
regulation by speciﬁc miRNAs to accelerate endothelial cell
senescence (Li et al., 2009). Moreover, a new function of Tnni2
in the regulation of bone developmentmay have also advanced
current understanding of the pathological mechanism of human
DA2B disorder (Zhu et al., 2014).
Research in the roles of cellular organelles
and subcellular structures in aging
Various membranous organelles, including the nucleus, mi-
tochondria, endoplasmic reticulum, peroxisomes, lysosomes,
and endosomes, may undergo degenerative changes playing
signiﬁcant roles in cell aging. Current research showed that
damages and reduced numbers of cellular organelles (such
as mitochondria, endoplasmic reticulum, peroxisomes, and
lysosomes) are closely related to the occurrence of aging and
aging-related diseases (Wang et al., 2014; Yang and Zhang,
2014; Zhang et al., 2014). Aging and related diseases are also
associatedwith the imbalance of protein homeostasis. Protein
stability and normal function in cells are ensured by a precise
quality control system including the roles of protein folding,
oxidation–reduction of heat shock protein in the endoplasmic
reticulum, and the protein degradation system by ubiquitin/
non-ubiquitin–proteasome mediated mechanisms (Rubin-
sztein et al., 2011; Tomaru et al., 2012). The reduction of the
mitochondrial respiratory chain transfer efﬁciency, electronic
leak, and ATP synthesis decline often occurred in aging,
leading to mitochondrial abnormalities and alteration of re-
active oxygen species levels (Green et al., 2011; Vendelbo
and Nair, 2011).
A major advance in longevity has been on the metabolic
signaling, mitochondrial and autophagy activity regulation.
The mTOR inhibitor rapamycin signiﬁcantly extended the
lifespan of laboratory organisms attributed to activation of
autophagy (Bjedov et al., 2010; Spong and Bartke, 2012;
Wilkinson et al., 2012). Similarly, autophagy inducing agent
spermidine has been shown to extend the lifespan of model
organisms (Eisenberg et al., 2009). Activating the signaling
pathways of EGF increases the number of ubiquitin-protea-
somes, and delays the aging of nematodes (Liu et al., 2011b),
whilst the lifespan of yeast can be prolonged by deubiquiti-
nation enzyme inhibitors to enhance activity of the protea-
some (Kruegel et al., 2011). Abnormal mitochondrial function
is linked to aging-related diseases. Notably, a newly-cloned
receptor of mitochondrial autophagy, FUNDC1, that interacts
with LC3 in mediating mitochondrial autophagy, is identiﬁed
as a target potentially regulating cell aging (Liu et al., 2014).
Furthermore, the membrane caveolae protein PTRF is also
involved in cell aging (Bai et al., 2011).
In contrast to stress regulation of cellular organelle functions
in aging, research in the structural damage in chromosomes
has been concentrated on gene loci and such non-coding re-
gions as telomeres. The accumulation of telomere DNA losses
including gradually shortened telomere length due to declined
telomerase activity plays an important role in the aging process
of tissues, organs, and organisms, as well as the development
of aging-related diseases (Cong et al., 1999; Cassar et al.,
2008; Xu et al., 2008; Nicholls et al., 2012; Ding et al., 2013;
Zhou et al., 2014). It has been demonstrated that telomerase
mutations cause aging-related diseases such as idiopathic
pulmonary ﬁbrosis. Telomerase activity may be closely related
to the aging and lifespan of individual organisms, but abnormal
activation of telomerase plays a key role in immortalization of
cancer cells (Armanios and Blackburn, 2012; Xu et al., 2014).
Meanwhile, telomereextensionby telomerase requiresspeciﬁc
conformational change (Wang et al., 2012a). It has been dis-
covered that telomerase is regulated by protein complexes in-
cluding telomere protein complex shelterin, a six protein
complex of TRF1, TRF2, POT1, TIN2, Rap1, and TPP1, and
that TIN2 also plays an important role in mediating the inter-
actions between telomeres and mitochondria (Liu et al., 2004;
O’Connor et al., 2006; Xin et al., 2007; Chen et al., 2012; Han
et al., 2013; Zhang et al., 2013).
Research in stem cell aging and regulatory mechanism
The induced pluripotent stem cells (iPSCs) technology en-
ables the creation of cell models of progeria and geriatrics in
laboratory conditions, for studying disease mechanisms and
drug screening. Meanwhile, human pluripotent stem cells
and gene targeting technologies can assist the knockout or
REVIEW Ruijuan Sun et al.









modiﬁcation of any protein from human stem cells, therefore
facilitating the functional study of the proteins in organisms
with aging and diseases (Liu et al., 2012b). However, the
ability of restoring telomere activity by somatic cell nuclear
transfer (SCNT) and induced pluripotent stem cells (iPSCs)
remains elusive. A recent study demonstrated that embry-
onic stem cells (Terc−/− ntESCs) from Terc−/− SCNTembryos
have stronger differentiation potential and self-renewal ca-
pacity compared with that of Terc−/− iPSCs. It is noteworthy
that the telomere lengths in SCNT cloned embryos are sig-
niﬁcantly lengthened, and the capping function of telomeres
in Terc−/− ntESCs is enhanced. In addition, the mitochondrial
function of Terc/iPSCs and their differentiated derivatives is
severely impaired, while the mitochondrial function in Terc−/−
ntESCs is considerably improved (Le et al., 2014). Recently,
a newly-identiﬁed p53 downstream gene, Gadd45a, was
found to be activated via p53-dependent and -independent
pathways, and involved in the regulation of cellular activity,
such as cell cycle checkpoints, apoptosis, DNA damage
repair, and signal transduction (Chen et al., 2014). Knockout
of miR-142a-3p gene from zebra ﬁsh leads to a decline in the
number of HSCs in aorta-gonad-kidney (AGM) region, as
well as the number of T cells in the thymus. Mechanism
study shows that miR-142a-3p regulates the formation and
differentiation of HSCs by inhibiting the mediated inﬂam-
matory signaling of the interferon regulatory factor 7 (irf7). Of
note, miR-142-3p also plays an important role in the forma-
tion of HSCs in the AGM region in a mouse, suggesting it
plays a highly conserved role in invertebrates (Lu et al.,
2013).
Research in signal transduction and epigenetic
regulation of aging
Increasing evidence showed that unlike gene mutation or
deletion, epigenetic changes during the aging process of
organism can be reversed, making it a promising target to
attenuate the aging process. Increases in H4K16 acetyla-
tion, H4K20 trimethylation, H3K4 trimethylation, and H3K9
trimethylation levels, and decreases of H3K9 methylation
and H3K27 trimethylation levels, have been used as aging-
related epigenetic markers (Krishnan et al., 2011; Liu et al.,
2012a; Liu et al., 2013). Besides, H3K4 dimethylation ac-
cumulates in aging brain in association with two H3K4
methyltransferases, SETD7, and DPY30 (Han et al., 2012),
while progressive increases in gene expression and loss of
H3K27me3 on IIS components are partly due to increased
activity of the H3K27 demethylase UTX-1 during aging (Jin
et al., 2011). A recent study revealed that p16 is a down-
stream gene of FOXA1 and leads to a decline of nucleosome
density in aging cell p16 gene promoter region, and thus
promoting the transcriptional activation of FOXA1 to p16 (Li
et al., 2013). Moreover, p16 3′UTR mRNA methylation pro-
vides an important approach for p16 up-regulation in the cell
aging process induced by oxidative stress (Zhang et al.,
2012b) and that microRNA can identify the coding region
and 5′UTR, such as Let-7 that can identify the p66Shc
coding region to regulate cellular senescence and lifespan
(Xu et al., 2014). Characterized by tissue speciﬁcity and
high-efﬁcient speciﬁcity targeting at target genes, microRNA
may be able to provide a new basis for clinical diagnosis and
a new therapeutic approach for some age-related diseases.
Regulation in signaling networks
It is well-known that regulation of insulin-like signaling plays
an important role in growth retardation, obesity, type 2 dia-
betes, life span, and oxidative resistance (Song et al., 2010).
The anti-aging effect of YAP2 has been discovered since
down-regulating or silencing YAP2 induces replicative se-
nescence of IMR90 human diploid cells in a TEAD and
Rb/p16/p53 pathway-dependent manner (Xie et al., 2013).
The hepatic IRE1α promotes the adaptive shift of fuel uti-
lization during starvation by stimulating mitochondrial β-
oxidation and ketogenesis through the XBP1 s-PPARα axis
(Shao et al., 2014). Furthermore, the Grb10/mTOR signaling
pathway has been identiﬁed to impact the biological changes
of adipose tissue and the “brown” process of white adipose
tissue (Zhang et al., 2012a; Liu et al., 2014). Intriguingly,
RIG-I/MAVS signaling pathway has been found to mediate
senescence and aging inﬂammation. The inﬂammation re-
sponse associated with cell senescence is signiﬁcantly de-
creased in MAVS-deﬁcient cells and mice. By contrast,
interfering with RIG-I in replicative senescence cells can
reduce the inﬂammation response of aging and slow the cell
aging process. Further research shows that the anti-aging
protein Klotho can act as RIG-I inhibitor to antagonize RIG-I-
induced senescence inﬂammation response, while knockout
of Klotho leads to a signiﬁcantly enhanced inﬂammatory
response (Liu et al., 2011a).
SIGNIFICANCE OF BASIC RESEARCH ON AGING
Aging-related diseases are featured by their close relation-
ship to age and they often occur in speciﬁc tissues and or-
gans. The aging of speciﬁc cell(s) inﬂames surrounding cells
of the same and other cell types leading to tissue degen-
eration, and continuous accumulation results in irreversible
losses of differentiated function and pathological changes of
the diseased tissue. Anti-aging is also a process involving
corrections and/or removals of damaged molecules, the
clearance of senescent cells, as well as proliferation and
differentiation of stem/progenitor (precursor) cells. Aging and
anti-aging process coexist as aging, anti-aging factors, and
injury, repair and regeneration are also in parallel. For in-
stance, interactions of inert and reactive bioactive assem-
blies and the consequent chemical reaction would free or
slowly cross-link the biological molecules, and altered ox-
idative product may produce damaging molecules pre-
cipitating aging of the biological tissues. In addition, aging
and damage of cellular organelles may be the patho-
physiological basis of many neural aging-related diseases
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such as Alzheimer’s disease (AD) and Parkinson’s disease
(PD), while the replication and regeneration of cells may be
the promising approach to vanquish many mitotic aging-re-
lated diseases (Liu, 2014). Mobilizing endogenous factors
and making use of exogenous anti-aging regimes to repair
damages and promote regeneration are important mechan-
isms to prevent and treat aging-related diseases. Recently,
alcohol dehydrogenase 5 (ADH5) is found to be a novel
suppressor of neuronal differentiation and maturation, sug-
gesting that ADH5 may improve adult neurogenesis in a
physiological or pathological setting (Wu et al., 2014). Aging
and anti-aging processes are in mutual checks and balances
in both damaging and regenerating. The body condition
reaches a steady status through the complicated coordina-
tion and interaction of molecules, cells and organs. The im-
balances of aging and anti-aging may instigate diseases of
related tissues and organs which become the key patho-
logical node for many major diseases occurred simultane-
ously in elderly people. Despite the inevitability of human
aging, aging can be delayed, and many related diseases are
preventable.
Aging of the organism, tissues, and organs is the main
cause of functional decline, and the premature aging of tis-
sues and organs is the utmost pathological basis for chronic
degenerative diseases. Tissue and organ speciﬁcity of aging
are common for most chronic degenerative diseases, such as
AD, atherosclerosis, pulmonary ﬁbrosis, muscular dystrophy,
osteoporosis, obesity, diabetes, menopause syndrome,
which are related to the premature aging of tissue-speciﬁc
cells. Aging of organism, tissues, or cells is a complicated and
irreversible process, but the time when it occurs and the pace
of the process may be regulated. Facing the need to slow
down the aging process of the organism and organs, as well
as to prevent common chronic diseases, a fundamental un-
derstanding of the cause of aging and the causes of aging
developing into diseases is a hot topic in the current medical
biological research ﬁeld (Kirkwood, 2008; Lopez-Otin et al.,
2013). Currently, extensive research has been laid on the
homology of the pathogenic causes for many aging-related
diseases and the fundamental mechanism for organism ag-
ing. Research on aging-inducing genes or the aging genes,
their mechanisms and unknown aging-related genes has
been attracting increasingly more attention (Hayﬂick, 2007;
Wolff and Dillin, 2013). Multiple causes for aging-related dis-
eases of organism include: (1) Chromosomal damages, gene
mutations, and epigenetic abnormalities; (2) Mitochondrial
damages, accumulation of lipid peroxidation products and
lipofuscin caused by reactive oxygen species; (3) Diabetes
caused by high blood sugar and accumulation of advanced
glycation end products in a variety of cells and tissues; (4)
Denatured fracture and cross-linking of collagen and elastin;
(5) Protein misfolding, denaturation, and accumulation of in-
soluble polymer; (6) Abnormal transport of small molecules,
recycling barriers of cells, organelles, proteins, and other
macromolecules; (7) Tissue inﬂammation, cell interactions,
and homeostasis disorders; (8) Homeostasis decline caused
by imbalance of hormone and immune cells etc. (Green et al.,
2011; Blagosklonny, 2012). All these problems are likely to
cause lesions of speciﬁc organs and systems, resulting in
aging-related diseases.
Challenges and weaknesses in aging research in China
remain obvious in manifolds. Most importantly, aging (espe-
cially premature aging) has not been well recognized as the
primary factors of most non-infectious chronic diseases.
Although the central government has been increasing its re-
search budgets continuously in aging research, contributions
from the state governments and the private sections have not
been considered as high priority to aging research and de-
velopment. As a matter of fact, with improved living conditions
and life expectancies in China, there are signiﬁcant demands
and interests of the general population in detecting premature
aging and delaying aging occurrence. In addition, interna-
tional collaborations in promoting aging research have until
recently been on the agenda including our organizing the
“Shuangqing” forum and a number of other activities from
universities, hospitals, and Chinese Academy of Science.
Unfortunately, a national-wide database incorporating infor-
mation of aging-related resources is yet to be established,
which requires urgent actions from aging research organiza-
tions and researchers. On the other hand, collaborations be-
tween hospitals and basic research institutes are lacking
which hinders the development of gerontology and geriatrics.
The phenomenon of being more difﬁcult for an aging disease
to ﬁnd its way to geriatrics than for ill children to be sent to
pediatrics may well reﬂect currently poor understandings of
the mechanisms and biomarkers of aging bodies for clinical
practice, making the translational aging research struggle to
develop. While many challenges and weakness of aging re-
search in China may be shared by global situations, we
highlight at least but not last the following a few that are
particularly sought after for development in China:
(1) The impact of particular environmental factors, various
foods, and exercise levels on aging and lifespan, (2) Genetic
traits and epigenetic speciﬁcities affected by stress in pre-
mature aging and aging related diseases including metabolic
disorder and cancers in liver, digestive tracts, and lung, (3)
Effect of endocrine/paracrine/autocrine hormones and cy-
tokines, microorganisms, inﬂammatory/immune responses
on tissue and organ aging, (4) Repair mechanisms of stem
cells and key enzyme molecules in aging damages, (5)
Tissue- and organ-speciﬁc mechanisms of aging and diag-
nostic markers.
OBJECTIVES AND STRATEGIES OF AGING
RESEARCH
Numerous tasks need to be done prior to achieving the ﬁnal
goal of preventing and reducing aging-related diseases. By
means of original innovative research, it would be important
to achieve 3 major comprehensive objectives. Firstly, at the
molecular and cellular levels, it would be important to un-
derstand the basis of aging, to clarify the molecular
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characteristics of different types of cellular aging and their
roles in the aging of tissues and organs, regulatory networks,
plasticity, and clearance mechanisms; to clarify the regula-
tory mechanism of the change of sub-cellular structure of
eukaryotic cell aging in aging and anti-aging process; to
clarify the basic structure and spatial conformation of differ-
ent key molecules and to analyze the binding structural do-
main of interacting molecules and small molecules; to
analyze direct and indirect (epi-)genetic regulatory network
of different genes, especially to identify and control the key
transcription factors mediating aging process; to unveil the
regulation and effect of key environmental factors, especially
the microﬂora in different tissues (such as intestine), ex-
cessive nutrients, toxic molecules, as well as exercises and
sleep, etc. on the aging of tissues and organs.
Second, at the levels of tissue- and organ-speciﬁc aging,
it would be important to clarify the transition of aging damage
to pathological damage and the composition and structural
alteration; to clarify the source, function, and regulatory en-
vironment of triggers to aging and aging-related diseases; to
clarify the susceptible parts of aging organelle/tissue/organ,
and the complicated etiology of aging-related diseases; to
rationalize and establish the relationship among the causes,
to strengthen the research in the compensatory effect of
aging development into aging-related diseases; to set out
the mechanism, reagents, and methods for early intervention
in the transition from aging to aging-related diseases in the
micro environment; to clarify the deﬁnition of physiological
aging and pathological aging of organisms as well as the
deﬁnition of healthy lifespan; to clarify the similarities and
differences in the lifespan regulation of non-vertebrates, in-
vertebrates, and mammals and to clarify the disease sus-
ceptibility and resistance mechanisms of different models to
aging-related diseases; to clarify the functional ingredients of
natural medicine (including Chinese medicine), the role of
new, small molecule compounds and clinical drugs (such as
rapamycin, metformin), and the regulatory mechanism of
other environmental factors to mammalian lifespan.
Third, at the levels of particular diseases, it would be im-
portant to clarify the role of signaling pathway impairment and
pathological basis in the occurrence and development of
aging-related diseases through the analysis of animal/human
disease models; to clarify the role of stem (precursor) cells
and their aging in aging and different common aging-related
diseases; to clarify the molecular biological characteristics
and development in the research models of brain aging-re-
lated diseases (such as PD, AD and common cognitive im-
pairment), vascular aging-related diseases, marrow aging-
related diseases, lung aging-related diseases, and ovarian
aging-related diseases; to clarify the mechanisms of pre-
vention of aging-related diseases via either inhibiting key
aging molecules or activating anti-aging molecules, thus
providing the basis and strategies for further research on the
prevention and treatment.
It is possible that senescence of a single or a group of
cells in certain tissues and organs seeds tissue speciﬁc
aging which paves, and is a prelude of, aging-related dis-
eases. Such senescent cells suffer irreversible damages,
therefore being ampliﬁed to cause loss of normal function of
aged tissues and organs. Current aging research in China
may need to collaborate with researchers in other countries
to integrate the approaches of molecular imaging, stem cell
biology, molecular genetics and genomics, molecular
pathology, histology and embryology, systematic biology,
bioinformatics, and clinical medicine to conduct research at
different levels of aging and related diseases. Research of
aging and aging-related diseases is a great challenge and
opportunity in the 21st century. Although it has experienced
a long history, aging research is still limited especially on the
transition from aging to aging diseases. In-depth and ex-
tensive exploration on key molecules and critical mechan-
isms are still very much sought after. The complexities of
various body tissues and differences in structures and
functions bring massive difﬁculties in human anti-aging re-
search. However, the discovery of stem cell plasticity, and
continuous breakthroughs in veriﬁcation of the causal rela-
tionship between molecules and aging-related diseases, for
example, using different cell culture systems and animal
models, have provided opportunity for collaborative innova-
tion in the research on aging and aging-related diseases.
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